Working with DICOM at scale?
DICOMAnon helps imaging teams anonymize, batch process, and automate DICOM workflows without writing custom scripts.
Author profile
Moffitt Cancer Center
DICOMAnon helps imaging teams anonymize, batch process, and automate DICOM workflows without writing custom scripts.
Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Lung function requires a close interaction between pulmonary circulation, the respiratory pump, and lung parenchyma. Diseases of the respiratory system can impact each of these components, therefore differentiation between the individual components and contri...
Glomerular Filtration Rate (GFR) is the most useful clinical indicator of renal function for staging kidney disease, adjustment of drug dosages, and screening for X-ray contrast administration. GFR may be estimated via plasma and/or urinary methods (eGFR) usi...
The American College of Radiology (ACR) has long been relied upon by the medical physics community to publish QC guidance that is practical and well-considered. After years of anticipation, the ACR has finally published QC manuals for NM/SPECT (2024) and PET...
The recently published Appropriate Use Criteria for Molecular Breast Imaging (MBI) by an expert workgroup has identified two clinical scenarios where MBI may serve an important role in the management of breast cancer patients: 1) supplemental screening in wom...
At the AAPM 2025 conference, these speakers conducted a 90-minute session titled “Building a Radiopharmaceutical Therapy Program and Expanding to Clinical Trials.” Following the talks and the ten-minute Q&A session, the audience continued to ask questions for...
Builds on the AI theme from AAPM's 2025 Annual Meeting while moving from image interpretation to quantitative, treatment-enabling applications. This is an area of growing convergence between SNMMI and AAPM. Focus: How AI and machine learning are transforming...
Nuclear medicine is currently experiencing significant growth, driven largely by the expanding use of radiopharmaceutical therapies. This growth has renewed interest in SPECT/CT system design, particularly the transition from conventional dual-headed NaI-base...
For decades, PET imaging was nearly synonymous with FDG. With improvements in PET technology, investment resulting from the emergence of theranostics, and improvements in reimbursement, the landscape of PET has shifted dramatically in recent years. Brain path...